The impact of periodontal infections on systemic diseases. An update for medical practitioners

Saudi Medical Journal

Volumn 27, Issue 6, 2006, Pages 767-776

  Anil, Sukumaran ^a   Al Ghamdi, Hamdan S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; INSULIN;

BACTERIAL STRAIN; BIOFILM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DENTAL HEALTH; DENTIST; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; INFECTION RISK; ISCHEMIC HEART DISEASE; LOW BIRTH WEIGHT; MEDICAL RESEARCH; MOUTH HYGIENE; NONHUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PHYSICIAN; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTEMIC DISEASE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LUNG DISEASES; MALE; OSTEOPOROSIS; PERIODONTAL DISEASES; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 33746392314     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72: 1221-1227.
2. Kesavalu L, Chandrasekar B, Ebersole JL. In vivo induction of proinflammatory cytokines in mouse tissue by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002; 17: 177-180.
3. Miller W. The Human Mouth as a Focus of infection. Dental Cosmos 1891; 33: 689-706.
4. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodonfol 1998; 3: 108-120.
5. Offenbacher S, Beck JD, Lieff S, Slade G. Role of periodontitis in systemic health: spontaneous preterm birth. J Dent Educ 1998; 62: 852-858.
6. Socransky SS, Haffajee AD. The bacteria] etiology of destructive periodontal disease: current concepts. J Periodontal 1992; 63 (4 Suppl): 322-331.
7. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993; 306: 688-691.
8. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996; 67 (10 Suppl): 1103-1113.
9. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998; 3: 51-61.
10. Scannapieco FA, Genco RJ. Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 1999; 34: 340-345.
11. Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2001; 25: 21-36.
12. Molloy J, Wolff LF, Lopez-Guzman A, Hodges JS. The association of periodontal disease parameters with systemic medical conditions and tobacco use. J Clin Periodontol 2004; 31: 625-632.
13. Scannapieco FA. Periodontal inflammation: from gingivitis to systemic disease? Compend Contin Educ Dent 2004; 25 (7 Suppl 1): 16-25.
14. Mattila KJ. Vital and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989; 225: 293-296.
15. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL- 1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160: 403-409.
16. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol 2001; 6: 91-98.
17. Nishimura F, Takahashi K, Kurihara M, Takashiba S, Murayama Y. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol 1998; 3: 20-29.
18. Anil S, Remani P, Vijayakumar T, Hari S. Cell-mediated and humoral immune response in diabetic patients with periodontitis. Oral Surg Oral Med Oral Pathol 1990; 70: 44-48.
19. Anil S, Remani P, Vijayakumar T, Joseph PA. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis. J Periodontol 1990; 61: 27-29.
20. Taylor GW, Manz MC, Borgnakke WS. Diabetes, periodontal diseases, dental caries, and tooth loss: a review of the literature. Compend Contin Educ Dent 2004; 25: 179-84, 186-188.
21. Mealey BL, Rethman MP. Periodontal disease and diabetes mellitus. Bidirectional relationship. Dent Today 2003; 22: 107-113.
22. Diaz-Romero RM, Casanova-Roman G, Beltran-Zuniga M, Belmont-Padilla J, Mendez JD, Avila-Rosas H. Oral infections and glycemic control in pregnant type 2 diabetics. Arch Med Res 2005; 36: 42-48.
23. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001; 6: 99-112.
24. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe petiodontal disease in die US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192.
25. Taylor GW, Burt BA, Becker UP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996; 67 (10 Suppl): 1085-1093.
26. Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 2001; 6: 138-145.
27. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis 2005; 11: 293-298.
28. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 2003; 74: 1361-1367.
29. Seppala B, Seppala M, Ainamo J. A longitudinal study on insuhn-dependent diabetes mellitus and periodontal disease. J Clin Periodontol 1993; 20: 161-165.
30. Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol 1996; 23: 194-202.
31. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 1997; 24: 505-510.
32. Collin HL, Uusitupa M, Niskanen L, Kontturi-Narhi V, Markkanen H, Koivisto AM, et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998; 69: 962-966.
33. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-1248.
34. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119-125.
35. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
36. Winkler G, Salamon F, Harmos G, Salamon D, Speer G, Szekeres O, et al. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. Diabetes Res Clin Pract 1998; 42: 169-174.
37. Njoroge T, Genco RJ, Scjar HT, Hamada N, Genco CA. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun 1997; 65: 1980-1984.
38. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997; 107: 347-352.
39. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998; 66: 5337-5343.
40. Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998; 3: 40-50.
41. Stein SH, Hart TE, Hoffman WH, Hendrix CL, Gustke CJ, Watson SC. Interleukin- 10 promotes anti-collagen antibody production in type 1 diabetic peripheral B lymphocytes. J Periodontal Res 1997; 32: 189-195.
42. Sims TJ, Lernmark A, Mancl LA, Schifferle RE, Page RC, Persson GR. Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis. J Clin Periodontol 2002; 29: 551-562.
43. Armitage GC. Periodontal infections and cardiovascular disease - how strong is the association? Oral Dis 2000; 6: 335-350.
44. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67 (10 Suppl): 1123-1137.
45. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J 1999; 138: S528-S533.
46. Arbes SJ Jr., Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 1999; 78: 1777-1782.
47. Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 2001; 6: 9-15.
48. Herzberg MC, Weyer MW. Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 1998; 3: 151-160.
49. Kinane DR Periodontal diseases' contributions to cardiovascular disease: an overview of potential mechanisms. Ann Periodontol 1998; 3: 142-150.
50. Losche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000; 27: 537-541.
51. Kang IC, Kuramitsu HK. Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol 2002; 34: 311-317.
52. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000; 84: 149-161.
53. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000; 79: 49-57.
54. Glurich I, Grossi S, Albini B, Ho A, Shah R, Zeid M, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 2002; 9: 425-432.
55. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000; 71: 1528-1534.
56. Stelzel M, Conrads G, Pankuweit S, Maisch B, Vogt S, Moosdorf R, et al. Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol 2002; 73: 868-870.
57. Pham K, Feik D, Hammond BF, Rams TE, Whitaker EJ. Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. Platelets 2002; 13: 21-30.
58. Hamada N, Watanabe K, Arai M, Hiramine H, Umemoto T. Cytokine production induced by a 67-kDa fimbrial protein from Porphyromonas gingivalis. Oral Microbiol Immunol 2002; 17: 197-200.
59. Roberts FA, Richardson GJ, Michalek SM. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun 1997; 65: 3248-3254.
60. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 2002; 81: 186-191.
61. Lavelle C. Is periodontal disease a risk factor for coronary artery disease (CAD)? J Can Dent Assoc 2002; 68: 176-180.
62. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000; 284: 1406-1410.
63. Janket SJ, Baird A, Chuang SK, Jones JA. Heart of the matter. J Am Dent Assoc 2001; 132: 1648-1652.
64. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med 2000; 160: 2749-2755.
65. Shoenfeld Y, Sherer Y, Harats D. Arthrosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001; 22: 293-295.
66. Scannapieco FA. Role of oral bacteria in respiratory infection. J Periodontol 1999; 70: 793-802.
67. Scannapieco FA, Ho AW, Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol 2001; 72: 50-56.
68. Scannapieco FA, Rethman MP. The relationship between periodontal diseases and respiratory diseases. Dent Today 2003; 22:79-83.
69. Terpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc 2001; 49: 557-563.
70. Garcia RI, Nunn ME, Vokonas PS. Epidemiologic associations between periodontal disease and chronic obstructive pulmonary disease. Ann Periodontol 2001; 6: 71-77.
71. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000; 26: 1239-1247.
72. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55: 114-120.
73. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118: 1557-1565.
74. Yumoto H, Nakae H, Fujinaka K, Ebisu S, Matsuo T. Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenelta corrodens. Infect Immun 1999; 67: 384-394.
75. Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, et al. Interactions between periodontal bacteria and human oral epithehal cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 2000; 68: 3140-3146.
76. Scannapieco FA, Wang B, Shiau HJ. Oral bacteria and respiratory infection: effects on respiratory pathogen adhesion and epithelial cell proinflammatory cytokine production. Ann Periodontol 2001; 6: 78-86.
77. Williams CE, Davenport ES, Sterne JA, Sivapathasundaram V, Fearne JM, Curtis MA. Mechanisms of risk in preterm low-birthweight infants. Periodontol 2000; 23: 142-150.
78. Grandi C, Tapia J, Marshall G. Severity, proportionality and risk of neonatal mortality of very low birth weight infants with fetal growth restriction. A multicentric South American analysis. Pediatr Res 2005; 57: 921.
79. Offenbacher S, Jared HL, O'Reilly PG, Wells SR, Salvi GE, Lawrence HP, et al. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 1998; 3: 233-250.
80. Boutigny H, Boschin F, Delcourt-Debruyne E. Periodontal diseases, tobacco and pregnancy. J Gynecol Obstet Biol Reprod 2005; 34:74-83.
81. Romero R, Baumann P, Gomez R, Salafia C, Rittenhouse L, Barberio D, et al. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and aniniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol 1993; 168: 1654-1664.
82. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990; 75: 622-626.
83. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319:972-978.
84. Kornman KS, Loesche WJ. The subgingival microbial flora during pregnancy. J Periodontal Res 1980; 15: 111-122.
85. Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997; 14: 12-32.
86. Dasanayake AP. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann Periodontol 1998; 3: 206-212.
87. Loesche WJ. Association of the oral flora with important medical diseases. Curr Opin Periodontol 1997; 4: 21-28.
88. Fowler EB, Breault LG, Cuenin MF. Periodontal disease and its association with systemic disease. Mil Med 2001; 166: 85-89.
89. Dowsett SA, Kowolik MJ. Oral Helicobacter pylori: can we stomach it? Crit Rev Oral Biol Med 2003; 14: 226-233.
90. Marshall JR, Graham S, Haughey BP, Shedd D, O'Shea R, Brasure J, et al. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Eur J Cancer B Oral Oncol 1992; 28B: 9-15.
91. Zheng TZ, Boyle P, Hu HF, Duan J, Ran PJ, Ma DQ, et al. Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990; 1: 235-241.
92. Balaram P. Sridhar H, Rajkumar T, Vaccarella. S, Herrero R, Nandakumar A, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002; 98: 440-445.
93. Velly AM, Franco EL, Schlecht N, Pintos J, Kowalski LP, Oliveira BV, et al. Relationship between dental factors and risk of upper aerodigestive tract cancer. Oral Oncol 1998; 34: 284-291.
94. Watabe K, Nishi M, Miyake H, Hirata K. Lifestyle and gastric cancer: a case-control study. Oncol Rep 1998; 5: 1191-1194.
95. Peach HG, Pearce DC, Farish SJ. Helicobacter pylori infection in an Australian regional city: prevalence and risk factors. Med J Aust 1997; 167: 310-313.
96. Avcu N, Avcu F, Beyan C, Ural AU, Kaptan K, Ozyurt M, et al. The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 166-169.
97. Ozdemir A, Mas MR, Sabin S, Saglamkaya U, Ateskan U. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. Quintessence Int 2001; 32: 131-134.
98. Kim N, Lim SH, Lee KH, You JY, Kim JM, Lee NR, et al. Helicobacter pylori in dental plaque and saliva. Korean J Intern Med 2000; 15: 187-194.
99. Dye BA, Kruszon-Moran D, McQuillan G. The relationship between periodontal disease attributes and Helicobacter pylori infection among adults in the United States. Am J Public Health 2002; 92: 1809-1815.
100. Forman D. Helicobacter pylori: the gastric cancer problem. Gat 1998; 43 Suppl 1: 33-34.
101. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, Virtamo J, Taylor PR, Albanes D. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am J Clin Nutr 2003; 78: 176-181.
102. Chauncey HH, Muench ME, Kapur KK, Wayler AH. The effect of the loss of teeth on diet and nutrition. Int Dent J 1984; 34: 98-104.
103. Joshipura KJ, Willett WC, Douglass CW. The impact of edentulousness on food and nutrient intake. J Am Dent Assoc 1996; 127: 459-467.
104. Desai HG, Gill HH, Shankaran K, Mehta PR, Prabhu SR. Dental plaque: a permanent reservoir of Helicobacter pylori? Scand J Gastroenterol 1991; 26: 1205-1208.
105. Kamat AH, Mehta PR, Natu AA, Phadke AY, Vora IM, Desai PD, et al. Dental plaque: an unlikely reservoir of Helicobacter pylori. Indian J Gastroenterol 1998; 17: 138-140.
106. Oshowo A, Gillam D, Botha A, Tunio M, Holton J, Boulos P, et al. Helicobacter pylori: the mouth, stomach, and gut axis. Ann Periodontol 1998; 3: 276-280.
107. Nguyen AM, el-Zaatari FA, Graham DY. Helicobacter pylori in the oral cavity. A critical review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 705-709.
108. Jeffcoat MK, Geurs NC, Lewis CE. Osteoporosis and periodontal bone loss. Clin Calcium 2003; 13: 577-581.
109. Wactawski-Wende J. Periodontal diseases and osteoporosis. association and mechanisms. Ann Periodontol 2001; 6: 197-208.
110. Lundstrom A, Jendle J, Stenstrom B, Toss G, Ravald N. Periodontal conditions in 70-year-old women with osteoporosis. Swed Dent J 2001; 25: 89-96.
111. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000; 71: 1492-1498.
112. Weyant RJ, Pearlstein ME, Churak AP, Forrest K, Famili P, Cauley JA. The association between osteopenia and periodontal attachment loss in older women. J Periodontol 1999; 70: 982-991.
113. Scheidt-Nave C. Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001; 86: 2032-2042.
114. Johnson RB, Gilbert JA, Cooper RC, Dai X. Newton BI, Tracy RR, et al. Alveolar bone loss one year following ovariectomy in sheep. J Periodontol 1997; 68: 864-871.
115. Persson RE, Hollender LG, Powell LV, MacEntee MI, Wyatt CC, Kiyak HA, et al. Assessment of periodontal conditions and systemic disease in older subjects. I. Focus on osteoporosis. J Clin Periodontol 2002; 29: 796-802.
116. Yoshihara A. Seida Y, Hanada N. Miyazaki H. A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older adults. J Clin Periodontol 2004; 31: 680-684.
117. Krall EA. The periodontal-systemic connection: implications for treatment of patients with osteoporosis and periodontal disease. Ann Periodontol 2001; 6: 209-213.
118. El-Shinnawi UM, El-Tantawy SI. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 2003; 5: 5-10.
119. Amar S. Ran X. The impact of periodontal infection on systemic diseases. Med Sci Monit 2003; 9: 291-299.